M
Mark E. Wong
Researcher at University of Texas Health Science Center at Houston
Publications - 79
Citations - 4630
Mark E. Wong is an academic researcher from University of Texas Health Science Center at Houston. The author has contributed to research in topics: Bone regeneration & PLGA. The author has an hindex of 29, co-authored 75 publications receiving 4121 citations. Previous affiliations of Mark E. Wong include University of Texas at Austin & University of Texas Health Science Center at San Antonio.
Papers
More filters
Journal ArticleDOI
Gelatin as a delivery vehicle for the controlled release of bioactive molecules.
TL;DR: This review will emphasize how biomolecules released from gelatin controlled-release systems are able to retain their biological activity, allowing for their use in tissue engineering, therapeutic angiogenesis, gene therapy, and drug delivery applications.
Journal ArticleDOI
Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model
TL;DR: The results indicate that delivery of both growth factors may enhance bone bridging and union of the critical size defect compared to delivery of BMP-2 alone and suggests an interplay between these growth factors for early bone regeneration.
Journal ArticleDOI
Injectable biomaterials for regenerating complex craniofacial tissues.
TL;DR: In this review, injectable materials that form scaffolds or networks capable of both replacing tissue function early after delivery and supporting tissue regeneration over a time period of weeks to months are examined.
Journal ArticleDOI
Dose Effect of Dual Delivery of Vascular Endothelial Growth Factor and Bone Morphogenetic Protein-2 on Bone Regeneration in a Rat Critical-Size Defect Model
Simon Young,Zarana S. Patel,James D. Kretlow,Matthew B. Murphy,Paschalia M. Mountziaris,L. Scott Baggett,Hiroki Ueda,Yasuhiko Tabata,John A. Jansen,Mark E. Wong,Antonios G. Mikos +10 more
TL;DR: The dose effect of dual delivery of vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2 (BMP-2) on bone regeneration was investigated in a rat cranial critical-size defect and the addition of VEGF was unable to reverse this decrease in PBF, although improvements in the number of bridged defects did occur in some groups.
Journal ArticleDOI
Temporomandibular disorders: a review of etiology, clinical management, and tissue engineering strategies.
TL;DR: An analysis of native tissue characterization to assist clinicians in identifying tissue engineering objectives and validation metrics for restoring healthy and functional structures of the TMJ is followed by a discussion of current trends in tissue engineering.